James J. Loughlin
Mr. Loughlin has served on the Board of Directors at Edge Therapeutics Inc. since November of 2011 and is the current Chair of the Audit Committee. Since 2007, he has served as an independent director for Celgene Corporation, where he has chaired the Audit Committee. Mr. Loughlin has also been a member of Celgene’s Compensation Committee since 2008. He is a member of the Board of InspireMD, served as a member of the Board and lead director of Datascope Corporation and on the Board of Alfacell Corporation.
Mr. Loughlin retired after 40 years at KPMG LLP, one of the world’s leading professional accounting and business consulting firms. As a partner at KPMG, he served for five years as a member of the Board of Directors as well as National Director of the Pharmaceuticals Practice and as Chairman of the Pension and Investment Committee of the KPMG Board from 1995 through 2001.